Hlh

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-11-18
Clinical Trial Update: Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis [Phase 2]
Phase 2 clinical trial update for 68GaNOTA-Anti-MMR-VHH2 imaging agent across multiple indications including solid malignancies of the head …